Related Experiment Videos
Mesangial anionic sites are decreased in human focal glomerular sclerosis
1Department of Pathology, Dokkyo University School of Medicine, Shimotsuga-gun, Japan.
Abstract:
We studied the mesangial anionic sites in two patients with focal glomerular sclerosis (FGS), using polyethyleneimine as a cationic probe. The mesangial negative charge in the FGS patients was less than that in three control patients. The decrease in negative charge in FGS concerned the central, paramesangial, as well as the subendothelial region of the mesangium; the decrease was most pronounced in the central region. It is proposed that loss of mesangial negative charge may have pathogenic significance in FGS.
Insights
Focal glomerular sclerosis (FGS) is associated with reduced negative charge in kidney mesangial cells. This loss of charge, particularly in the central mesangium, may play a role in FGS development.
Area of Science:
- Nephrology
- Pathology
- Cell Biology
Background:
- Focal glomerular sclerosis (FGS) is a leading cause of kidney failure.
- The role of mesangial charge in FGS pathogenesis is not well understood.
Purpose of the Study:
- To investigate the mesangial anionic sites in patients with focal glomerular sclerosis (FGS).
- To compare the mesangial negative charge in FGS patients versus healthy controls.
Main Methods:
- Utilized polyethyleneimine as a cationic probe to study mesangial anionic sites.
- Compared charge density in the central, paramesangial, and subendothelial regions of the mesangium.
Main Results:
- Patients with FGS exhibited significantly lower mesangial negative charge compared to controls.
- The reduction in negative charge was most pronounced in the central mesangial region.
Conclusions:
- A decrease in mesangial negative charge may be a significant factor in the development of FGS.
- Further research is warranted to explore the therapeutic potential of targeting mesangial charge.